May 22, 2018 / 12:45 PM / a month ago

BRIEF-EyeGate Submits Investigational Device Exemption Amendment For Ocular Bandage Gel

* EYEGATE ADDRESSES MAJORITY OF FDA’S ACTION ITEMS WITH SUBMISSION OF INVESTIGATIONAL DEVICE EXEMPTION AMENDMENT FOR OCULAR BANDAGE GEL

* EYEGATE PHARMACEUTICALS INC - RESPONSE TO FOURTH ACTION ITEM EXPECTED IN Q2 OF 2018 WITH POTENTIAL TO START CLINICAL STUDY IN Q3 OF 2018

* EYEGATE PHARMACEUTICALS INC - WORK CONTINUES ON FILTER VALIDATION REQUIREMENT ASSOCIATED WITH EYEGATE OBG PRODUCT

* EYEGATE PHARMACEUTICALS - ADDRESSED THREE OF FOUR OUTSTANDING ITEMS IN SECOND AMENDMENT IN RESPONSE TO U.S. FDA’S REVIEW OF FIRST AMENDMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below